See the DrugPatentWatch profile for dupixent
Does Dupixent Cause Eye Irritation or Redness?
Yes, Dupixent (dupilumab) commonly causes eye-related side effects, including irritation, redness, itching, and dryness. These affect up to 20% of patients in clinical trials, often appearing within weeks of starting treatment.[1][2]
How Common Are These Eye Problems?
- Conjunctivitis (inflammation causing redness and irritation) occurs in 10-22% of patients, depending on the condition treated (e.g., atopic dermatitis or asthma).
- Dry eye, blurred vision, and keratitis (corneal inflammation) are reported in 1-10% of cases.
- Symptoms are more frequent with higher doses or in eczema patients.[1][3]
Why Does Dupixent Affect the Eyes?
Dupixent blocks IL-4 and IL-13 signaling, which reduces inflammation in skin or lungs but can disrupt the eye's protective mucus layer (goblet cells). This leads to dryness and irritation, especially in those prone to allergies or eczema.[2][4]
What Do Patients Report?
Real-world data shows eye issues prompt 2-5% of patients to stop treatment. Redness and burning often worsen initially, then stabilize with eye drops.[3][5]
How Are Eye Side Effects Managed?
- Use artificial tears or prescription drops (e.g., cyclosporine).
- Ophthalmologist consult if symptoms persist beyond 2 weeks.
- Dose adjustments or pauses rarely needed; most cases resolve without stopping Dupixent.[1][2]
Who Is at Higher Risk?
Patients with prior eye conditions, severe eczema, or asthma see higher rates (up to 28% for conjunctivitis). Children under 6 have lower incidence.[1][4]
When Should You See a Doctor?
Seek care for vision changes, severe pain, light sensitivity, or discharge, as untreated issues can lead to ulcers or scarring.[2][3]
[1]: Dupixent Prescribing Information (FDA)
[2]: Dupixent Safety Profile (Sanofi/Regeneron)
[3]: Clinical Trial Data (NEJM, 2016)
[4]: Ophthalmologic Review (JAMA Ophth, 2020)
[5]: FDA Adverse Event Reporting (FAERS)